Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Symptom Experience of Patients With Cutaneous Melanoma Receiving Immune Checkpoint Inhibitor Therapy

NCT07148245 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07148245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07148245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Symptom Experience of Patients With Cutaneous Melanoma Receiving Immune Checkpoint Inhibitor Therapy
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Recruiting
Start date
October 13, 2025
Completion date
June 30, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma, cutaneous melanoma by ajcc v7 stage, cutaneous melanoma, stage iii, cutaneous melanoma, stage iv